These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24209843)
41. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC. Lisovsky I; Kant S; Tremblay-McLean A; Isitman G; Kiani Z; Dupuy FP; Gilbert L; Bruneau J; Shoukry NH; Lebouché B; Bernard NF J Leukoc Biol; 2019 Mar; 105(3):551-563. PubMed ID: 30698860 [TBL] [Abstract][Full Text] [Related]
42. Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity. Almeida CR; Ashkenazi A; Shahaf G; Kaplan D; Davis DM; Mehr R PLoS One; 2011; 6(9):e24927. PubMed ID: 21949790 [TBL] [Abstract][Full Text] [Related]
43. The immune synapse clears and excludes molecules above a size threshold. Cartwright AN; Griggs J; Davis DM Nat Commun; 2014 Nov; 5():5479. PubMed ID: 25407222 [TBL] [Abstract][Full Text] [Related]
44. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637 [TBL] [Abstract][Full Text] [Related]
45. Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Golden-Mason L; Bambha KM; Cheng L; Howell CD; Taylor MW; Clark PJ; Afdhal N; Rosen HR; Hepatology; 2011 Nov; 54(5):1559-69. PubMed ID: 21983945 [TBL] [Abstract][Full Text] [Related]
46. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689 [TBL] [Abstract][Full Text] [Related]
47. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation. Roda-Navarro P; Reyburn HT J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438 [TBL] [Abstract][Full Text] [Related]
48. Educated natural killer cells show dynamic movement of the activating receptor NKp46 and confinement of the inhibitory receptor Ly49A. Staaf E; Hedde PN; Bagawath Singh S; Piguet J; Gratton E; Johansson S Sci Signal; 2018 Feb; 11(517):. PubMed ID: 29440510 [TBL] [Abstract][Full Text] [Related]
49. Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population. Hilton HG; Norman PJ; Nemat-Gorgani N; Goyos A; Hollenbach JA; Henn BM; Gignoux CR; Guethlein LA; Parham P PLoS Genet; 2015 Aug; 11(8):e1005439. PubMed ID: 26292085 [TBL] [Abstract][Full Text] [Related]
50. The Rac activator DOCK2 regulates natural killer cell-mediated cytotoxicity in mice through the lytic synapse formation. Sakai Y; Tanaka Y; Yanagihara T; Watanabe M; Duan X; Terasawa M; Nishikimi A; Sanematsu F; Fukui Y Blood; 2013 Jul; 122(3):386-93. PubMed ID: 23719299 [TBL] [Abstract][Full Text] [Related]
51. Association of NKG2A with treatment for chronic hepatitis C virus infection. Harrison RJ; Ettorre A; Little AM; Khakoo SI Clin Exp Immunol; 2010 Aug; 161(2):306-14. PubMed ID: 20550548 [TBL] [Abstract][Full Text] [Related]
52. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492 [TBL] [Abstract][Full Text] [Related]
53. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Fan QR; Long EO; Wiley DC Nat Immunol; 2001 May; 2(5):452-60. PubMed ID: 11323700 [TBL] [Abstract][Full Text] [Related]
54. CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse. Taouk G; Hussein O; Zekak M; Abouelghar A; Al-Sarraj Y; Abdelalim EM; Karam M Sci Rep; 2019 Jun; 9(1):8756. PubMed ID: 31217484 [TBL] [Abstract][Full Text] [Related]
55. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. Khaznadar Z; Henry G; Setterblad N; Agaugue S; Raffoux E; Boissel N; Dombret H; Toubert A; Dulphy N Eur J Immunol; 2014 Oct; 44(10):3068-80. PubMed ID: 25041786 [TBL] [Abstract][Full Text] [Related]
56. PD-1 blocks lytic granule polarization with concomitant impairment of integrin outside-in signaling in the natural killer cell immunological synapse. Huang Y; Chen Z; Jang JH; Baig MS; Bertolet G; Schroeder C; Huang S; Hu Q; Zhao Y; Lewis DE; Qin L; Zhu MX; Liu D J Allergy Clin Immunol; 2018 Oct; 142(4):1311-1321.e8. PubMed ID: 29679656 [TBL] [Abstract][Full Text] [Related]
57. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C Front Immunol; 2021; 12():619069. PubMed ID: 34108958 [TBL] [Abstract][Full Text] [Related]
58. A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Carlin LM; Evans R; Milewicz H; Fernandes L; Matthews DR; Perani M; Levitt J; Keppler MD; Monypenny J; Coolen T; Barber PR; Vojnovic B; Suhling K; Fraternali F; Ameer-Beg S; Parker PJ; Thomas NS; Ng T Sci Signal; 2011 Nov; 4(201):ra81. PubMed ID: 22126964 [TBL] [Abstract][Full Text] [Related]
59. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. Masilamani M; Nguyen C; Kabat J; Borrego F; Coligan JE J Immunol; 2006 Sep; 177(6):3590-6. PubMed ID: 16951318 [TBL] [Abstract][Full Text] [Related]
60. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals. Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]